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European guidelines on when to
start dialysis: check the facts first
before commenting
To the Editor: In his article commenting on the European
Renal Best Practice (ERBP) position statement on when to
start dialysis,1 Steven Rosansky disagrees with the European
guidelines2 and proposes his own recommendation that
dialysis should not be started until the patient is symptomatic.
In fact, ERBP’s recommendation is almost identical to that
advocated by Rosansky. The ERBP does not recommend
starting dialysis in an asymptomatic patient, except, possibly,
in those in whom the onset of symptoms may be particularly
difﬁcult to detect. Starting dialysis is only recommended when
the patient becomes symptomatic. Only the preparation for
dialysis should start earlier.
Rosansky states that ‘the new guidelines continue to promote
early dialysis for diabetics and for patients with poor nutritional
status’. In fact, the ERBP position statement only advocates
closer supervision in high-risk patients, not earlier dialysis.
Rosansky criticizes ERBP for ignoring studies, especially
his own, that show an association between starting dialysis at
a higher estimated glomerular ﬁltration rate (eGFR) and
decreased survival. In fact, the ERBP position statement
referenced six of these studies and commented ‘These studies
provide convincing and reproducible evidence that there is an
association between high eGFR when dialysis starts and
increased mortality.’ This association, already described in
1999,3 was referenced and taken into account in the original
2002 European guidelines on when to start dialysis.
This article demonstrates the need for a rigorous
collaborative process, such as that used by ERBP, to avoid
the almost inevitable bias if a monograph is generated by a
single individual.
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The Author Replies: I thank the European Renal Best
Practice (ERBP) advisory board1 for responding to my
editorial.2 My primary reason for writing the editorial was
to keep the issue in the academic arena and to help physicians
understand the complexity of the problem.2 The latest ERBP
guidelines focus on the IDEAL study and ‘do not include a
formal literature review’, which, in my opinion, is crucial
before issuing new guidelines.3 Our main area of disagree-
ment is the conclusion from the IDEAL study that ‘the
majority of patients will develop symptoms before a MDRD
eGFR of 6ml/min/1.73m2’. Although uremia is given as the
reason for 73% of patients who were assigned to late start but
who started early, the actual reason is unknown.4 The
conclusion that there is ‘high-quality evidence’ that patients
will have uremic symptoms at this level of estimated
glomerular ﬁltration rate (eGFR) is not supported by the
study.3 The extension of this conclusion that ‘delaying dialysis
until there are symptoms that would carry a risk of harm or
death due to uremia’ is not addressed in IDEAL. I am aware of
only one prospective study of intentional ‘late’ dialysis
initiation, an eGFR of 6ml/min per 1.73m2 (ref. 5). In this
study, Di Micco et al.5 enrolled 30 patients at an eGFR of
15ml/min per 1.73m2. Only 7 (23%) of the 30 patients had
any of nine listed reasons, one of which was ‘uremia’, to
initiate dialysis before an eGFR of 6ml/min per 1.73m2. Eight
patients did not start dialysis after 21.8 months, and 14 (47%)
started without developing any of the listed reasons at an
eGFR of 6ml/min per 1.73m2. Thus, it is unlikely that the
crossovers to early start in IDEAL were actually uremic. I
agree that we need studies relating criteria used to initiate
dialysis and outcomes. IDEAL does not provide any real
insight into this issue.
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